For research use only. Not for therapeutic Use.
Broxyquinoline, also known as Dibromoxyquinoline and NSC-1810, is a tetrahydrofolate dehydrogenase inhibitor used to treat vaginitis. Broxyquinoline induces VEGF transcription and shows angiogenic effects, stabilizes HIF-1α, and shows antiprotozoal and antifungal effects in vivo.
Catalog Number | A000812 |
CAS Number | 521-74-4 |
Synonyms | 5,7-Dibromoquinolin-8-ol; 521-74-4; 5,7-Dibromo-8-hydroxyquinoline; 5,7-Dibromo-8-quinolinol; Broxiquinoline |
Molecular Formula | C9H5Br2NO |
Purity | ≥95% |
Target | Tetrahydrofolate Dehydrogenase Inhibitor |
Storage | -20°C |
InChI | InChI=1S/C9H5Br2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H |
InChIKey | ZDASUJMDVPTNTF-UHFFFAOYSA-N |
SMILES | C1=CC2=C(C(=C(C=C2Br)Br)O)N=C1 |
Reference | 1: Swain R, Bapna JS. Impairment of exercise tolerance due to 2: Swain R, Bapna JS, Das AK, Chandrasekar S, Swaminathan RP, Bosco B, Veliath S, 3: Hazra SK, Ghosh S, Kundu SK, Chaudhuri S. Therapeutic trial of a combination <br> <br> 6: Rao SR, Rajyalaxmi K, Murthy KJ, Chandrasekhar VP. Anti-fungal activity of <br> <br> 9: Majumdar M, Majumdar H. Broxyquinoline and brobenzoxaldine with belladonna in <br> |